Home › Shoulder Injuries and Disorders › NCT06077942

FX Shoulder Solutions Retrospective / Prospective Clinical Study

RecruitingObservational study

Who can join

All ages · All sexes

Full eligibility criteria

Inclusion Criteria:

* Received an FX Shoulder Solutions replacement medical device in accordance with the Indications for Use based upon surgeons' determination and standard of care for the selected device system beginning January 1, 2018, through June 30, 2023.

Exclusion Criteria:

* Patient who does not meet the inclusion criteria above

About the study

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

What is being tested

FX Artificial Shoulder Prosthesis (device)

Sponsor: FX Shoulder Solutions · Participants: 600 · Started: Dec 6, 2022

Contact the study team

Ted McKittrick, BA · Phone: 7242493364
Brian Rogers, BS · Phone: 18002800775

Official record on ClinicalTrials.gov — NCT06077942

Locations in the U.S.

Arizona	OrthoArizona, Gilbert (Not yet recruiting)
Florida	Advanced Orthopedics Institute, The Villages

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.